ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0411

Outcomes in Juvenile Idiopathic Arthritis Based on Geographic Region in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry

Julia Harris1, Sheetal Vora2, Catherine Bingham3, Cagri Yildirim-Toruner4, Kerry Ferraro5, Erik Friedrichsen6, Katelyn Banschbach7, Jon Burnham8, Danielle Fair9, Mileka Gilbert10, Beth Gottlieb11, Tzielan Lee12, Melissa Mannion13, Edward Oberle14, Nancy Pan15, Natalie Rosenwasser16, Mary Toth17, Jennifer Weiss18 and Esi Morgan16, 1Children's Mercy Kansas City, Overland Park, KS, 2Atrium Health Levine Children's Hospital, Charlotte, NC, 3Penn State Children's Hospital, Hershey, PA, 4Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 5Pediatric Rheumatology Care and Outcomes Improvement Network, Cincinnati, 6Seattle Children's Hospital, Burien, WA, 7cincinnati Children's hospital, Villa Hills, KY, 8Children's Hospital of Philadelphia, Bryn Mawr, PA, 9Medical College of Wisconsin/Children's Wisconsin, Wauwatosa, WI, 10Medical University of South Carolina, Charleston, SC, 11Cohen Children's Medical Center, Northwell Health, Lake Success, NY, 12Stanford University School of Medicine, Palo Alto, CA, 13University of Alabama at Birmingham, Birmingham, AL, 14Nationwide Children's Hospital, Columbus, OH, 15Hospital for Special Surgery, New York, NY, 16Seattle Children's Hospital, seattle, WA, 17Nemours Foundation, Orlando, FL, 18Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ

Meeting: ACR Convergence 2025

Keywords: Juvenile idiopathic arthritis, Outcome measures, registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0387–0429) Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a learning health network focused on improving healthcare delivery and outcomes in patients with juvenile idiopathic arthritis (JIA). Measured disease activity outcomes include inactive or low disease activity by the 10-joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10), active joint count, and physician global assessment of disease activity (PhGA) score. PR-COIN also tracks patient-reported outcomes (PROs) including a patient/parent global assessment of overall wellbeing (PtGA) score, pain, and physical function. We sought to assess for any differences in disease activity and PROs based on geographic location of the PR-COIN sites.

Methods: We assessed PR-COIN registry data from 1/2023-2/2025. Geographical cohorts from the United States were divided into the following: Northeast, Midwest, South, and West. Cohort patient count, race, ethnicity, and insurance status were assessed. Run charts were created to portray data over time and medians were calculated. A low PtGA value indicates a score of ≤2 (0=very well, 10=very poor). No or mild pain is a value of ≤3 on the arthritis-related pain intensity scale (0=no pain, 10=severe pain). Optimal physical function is a score of 0 on the Childhood Health Assessment Questionnaire (CHAQ) or ≥40 on Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility or Upper Extremity Function.

Results: There are 2-5 sites and 800-2613 patients per geographic region (Table 1). White patients were a majority of the reported race (65.2-77.0%), with a sizable percentage being other or unknown (12.2-33.0%). Run charts stratified by geographic region are depicted in Figure 1. Medians for each disease activity measure and PRO varied by geographic region (Table 2). The percent of patients in inactive or low disease activity ranged from 74.9% (South) to 85.5% (Northeast). The West had the lowest active joint count (0.33), and the Midwest and South had the highest (0.80-0.81). The Midwest and South also had the highest PhGA values (0.66-0.68) with the West having a considerably lower value at 0.22. The West also had the least percentage of patients with a low PtGA (74.0%), and the Northeast had the highest percent (80.6%). No or mild pain ranged from 77.9% (Midwest) to 85.8% (South). Optimal physical function was bimodal with the Midwest and South ranging from 60.8-61.0% and the Northeast and West with 85.5-92.9% of their patients satisfying this measure.

Conclusion: Overall, a large proportion of patients with JIA in the PR-COIN registry are doing well with inactive or low disease activity, no or mild pain, and optimal physical function. We found differences in disease activity and PROs by geographic region. Limitations include missing data, variable data quality in relation to the percent of a site’s JIA population enrolled in the PR-COIN registry, and no control for patient mix (including JIA subtype and disease duration). Next steps include assessing processes of care by geographic region, patients in rural versus urban areas, variation in medication use, impact of social drivers of health, and considering geographic-specific workgroups and/or interventions.

Supporting image 1Table 1. Current patient count and characteristics of patients by geographic region.

Supporting image 2Table 2. Overall median performance by geographic region from January 2023 to February 2025.

Supporting image 3Figure 1. Examples of stratified run charts of quality measures by geographic region.


Disclosures: J. Harris: None; S. Vora: None; C. Bingham: None; C. Yildirim-Toruner: None; K. Ferraro: Abby's Army, 3, 8, 12, President; E. Friedrichsen: None; K. Banschbach: None; J. Burnham: Cabaletta Bio, 5; D. Fair: None; M. Gilbert: None; B. Gottlieb: None; T. Lee: None; M. Mannion: None; E. Oberle: Pfizer, 1; N. Pan: None; N. Rosenwasser: None; M. Toth: None; J. Weiss: None; E. Morgan: None.

To cite this abstract in AMA style:

Harris J, Vora S, Bingham C, Yildirim-Toruner C, Ferraro K, Friedrichsen E, Banschbach K, Burnham J, Fair D, Gilbert M, Gottlieb B, Lee T, Mannion M, Oberle E, Pan N, Rosenwasser N, Toth M, Weiss J, Morgan E. Outcomes in Juvenile Idiopathic Arthritis Based on Geographic Region in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/outcomes-in-juvenile-idiopathic-arthritis-based-on-geographic-region-in-the-pediatric-rheumatology-care-and-outcomes-improvement-network-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-in-juvenile-idiopathic-arthritis-based-on-geographic-region-in-the-pediatric-rheumatology-care-and-outcomes-improvement-network-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology